arrow
T

Tania Roskams

KU Leuven
H指数:100
被引数:3.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

TLR5 drives metabolic dysfunction-associated steatohepatitis through lipid- and flagellin-induced hepatocyte injury signaling

TLR5通过脂质和鞭毛素诱导的肝细胞损伤信号驱动代谢功能障碍相关脂肪性肝炎

2026-11-180
OA
Hippo signaling drives mesenchymal cell fate and heterogeneity in liver cancer

Hippo信号通路驱动肝癌中间充质细胞的命运和异质性

2026-10-150
OAAI
Claudin-1 targeting suppresses tumor growth, invasion, and metastasis in patient-derived cholangiocarcinoma models

靶向Claudin-1抑制患者来源的胆管癌模型的肿瘤生长、侵袭和转移

2026-01-010
OA
Retraction: α-1 adrenergic receptor agonists modulate ductal secretion of BDL rats via Ca2+- and PKC-dependent stimulation of cAMP

撤回:α-1肾上腺素能受体激动剂通过Ca2+和PKC依赖性刺激cAMP来调节BDL大鼠的导管分泌

2025-06-190
PRE
Steatotic liver disease induces YAP/TAZ-driven cell competition that can suppress tumor initiation

脂肪性肝病诱导YAP/TAZ驱动的细胞竞争,该竞争可抑制肿瘤起始

2025-06-060
PREAI
Intrinsic temperature increase drives lipid metabolism towards ferroptosis evasion and chemotherapy resistance in pancreatic cancer

内在性温度升高促使脂质代谢向铁死亡逃逸和胰腺癌化疗耐药方向发展

2024-10-020
OAAI
Diagnostic criteria and long-term outcomes in AIH-PBC variant syndrome under combination therapy
2024-07-012
OAAI
Single-cell RNA sequencing of cystic fibrosis liver disease explants reveals endothelial complement activation

囊性纤维化肝病外植体的单细胞RNA测序揭示了内皮补体激活

2024-06-073
PRE
Nucleotide metabolism in cancer cells fuels a UDP-driven macrophage cross-talk, promoting immunosuppression and immunotherapy resistance

癌细胞中的核苷酸代谢促进了UDP驱动的巨噬细胞串扰,促进了免疫抑制和免疫治疗抵抗

2024-06-067
OAAI
Treatment of cholangiocarcinoma using humanized monoclonal antibodies targeting claudin-1
2024-03-220
PRE
Adipose tissue macrophage dysfunction is associated with a breach of vascular integrity in NASH
2024-03-014
OA